Telangiectasis Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Telangiectasis Global Clinical Trials Review, H1, 2012" provides data on the Telangiectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Telangiectasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Telangiectasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Reasons to buy
Keywords
Telangiectasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Telangiectasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Summary
GlobalData's clinical trial report, “Telangiectasis Global Clinical Trials Review, H1, 2012" provides data on the Telangiectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Telangiectasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Telangiectasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Telangiectasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Telangiectasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Introduction
Telangiectasis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Manhattan Eye Ear & Throat Hospital
Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
Eye Center of Northern Colorado, P.C.
Clinical Trial Overview of Eye Center of Northern Colorado, P.C.
Asociacion para Evitar la Ceguera en Mexico I.A.P.
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P.
University of Sao Paulo
Clinical Trial Overview of University of Sao Paulo
Imperial College London
Clinical Trial Overview of Imperial College London
Bispebjerg Hospital
Clinical Trial Overview of Bispebjerg Hospital
Federal University of Sao Paulo
Clinical Trial Overview of Federal University of Sao Paulo
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Telangiectasis Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, Europe, Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, North America, Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, BRIC Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, G7 Countries, 2012*
Telangiectasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, E7 Countries, 2012*
Telangiectasis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Telangiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eye Center of Northern Colorado, P.C., 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
LIST OF FIGURES
Telangiectasis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, G7 Countries (%), 2012*
Telangiectasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, E7 Countries (%), 2012*
Telangiectasis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Telangiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Telangiectasis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Manhattan Eye Ear & Throat Hospital
Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
Eye Center of Northern Colorado, P.C.
Clinical Trial Overview of Eye Center of Northern Colorado, P.C.
Asociacion para Evitar la Ceguera en Mexico I.A.P.
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P.
University of Sao Paulo
Clinical Trial Overview of University of Sao Paulo
Imperial College London
Clinical Trial Overview of Imperial College London
Bispebjerg Hospital
Clinical Trial Overview of Bispebjerg Hospital
Federal University of Sao Paulo
Clinical Trial Overview of Federal University of Sao Paulo
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Telangiectasis Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, Europe, Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, North America, Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, BRIC Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, G7 Countries, 2012*
Telangiectasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, E7 Countries, 2012*
Telangiectasis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Telangiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eye Center of Northern Colorado, P.C., 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Telangiectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
LIST OF FIGURES
Telangiectasis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Telangiectasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Telangiectasis Therapeutics Clinical Trials, G7 Countries (%), 2012*
Telangiectasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, E7 Countries (%), 2012*
Telangiectasis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Telangiectasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Telangiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Telangiectasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
